HIV New Product Introduction Toolkit

CHAI has developed two new posters to support the introduction of pediatric Abacavir/Lamivudine/Dolutegravir (pALD) in health systems....

This tool was developed to support national HIV programs and ministries of health to estimate and compare the cost of the following two...

The GAP-f pDTG task team has developed a brief outlining product introduction and rollout considerations for national programmes when...

The Transitioning children to Optimal Regimens of Paediatric Dolutegravir (TORPEDO) Study was conducted in Benin, Nigeria, and Uganda....

Darunavir (DRV) is a best-in-class protease inhibitor (PI) used in combination with other antiretroviral (ARV) drugs for the...

CHAI has developed this memo to lay out information for national HIV programs considering the introduction of pediatric...

This document is intended to support country programs to develop clinical guidance and implementation plans for the introduction of the...

CHAI's TLD resources help countries in creating the best plan for TLD introduction. CHAI TLD Clinical Action Memo CHAI DTG Use In Women...

This tool is helpful for identifying the key stakeholders involved in new product introduction. This tool encourages users to think...

The CHAI New Product Rollout Planning Template is designed to provide a skeleton for Ministries of Health and implementing partners to...